References
Altman DG, Dore CJ. Randomization and baseline comparisons in clinical trials. Lancet 335: 149–153, 1990
Amery A, Birkenhaeger W, Brixko P, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure and previous cardiovascular disease in patients over the age of 60. Lancet 2: 589–592, 1986
Amery A, Birkenhaeger W, Brixko P, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1: 1349–1354, 1985
Anastos K, Charney P, Charon RA, et al. Hypertension in women: what is really known? Annals of Internal Medicine 115: 287–293, 1991
Bailer JC, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Annals of Internal Medicine 108: 266–273, 1988
Ball SG. Future approaches to the treatment of hypertension in the light of results from recent trials. Drugs 35(Suppl. 4): 9–15, 1988
Bateman DN, Chaplin S. Adverse reactions I. British Medical Journal 296: 761, 1988
Beck JR. How to evaluate drugs: cost-effectiveness analysis. Journal of the American Medical Association 254: 83–84, 1990
Birkenhaeger WH. Choosing the optimum therapy for older hypertensive patients. Drugs & Aging 1: 36–47, 1991
Birkenhaeger WH, de Leeuw PW. How far should blood pressure be lowered? Drugs 36: 7–10, 1988
Bulpitt CJ, Fletcher AE. Drug treatment and quality of life in the elderly. Clinics in Geriatric Medicine 6: 309–317, 1990
Burns R. Cost effectiveness in the treatment of hypertension. Clinics in Geriatric Medicine 5: 829–840, 1989
Coope J, Warrender T. Randomised trial of treatment of hypertension in elderly patients in primary care. British Medical Journal 293: 1145–1151, 1986
Cruickshank J. Coronary flow reserve and the J curve relation between diastolic blood pressure and myocardial infarction. British Medical Journal 297: 1227–1230, 1988
Curb JD, Borhani NO, Schnaper H, et al. Detection and treatment of hypertension in older individuals. American Journal of Epidemiology 121: 371–376, 1985
Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment of hypertension: a review. Hypertension 13(Suppl. 1): 36–44, 1989
Davidson RA, Caranasos GJ. Should the elderly hypertensive be treated? Evidence from clinical trials. Archives of Internal Medicine 147: 1933–1937, 1987
Denig P, Haaijer-Ruskamp FM, Zijsling DH. How physicans choose drugs. Social Science and Medicine 21: 1381–1386, 1988
Department of Clinical Epidemiology and Biostatistics, Mc-Master University Health Sciences Centre. How to read clinical journals. V. To distinguish useful from useless or even harmful therapy. Canadian Medical Association Journal 124: 1156–1162, 1981
Deyo RA. The quality of life, research and care. Annals of Internal Medicine 114: 695–696, 1991
Editorial. Guidelines for writing papers. British Medical Journal 296: 48–50, 1988
Edmonds D, Greminger P, Vetter W, et al. The neglected time factor and antihypertensive therapy. Postgraduate Medicine 83 (Spec. No.): 40–45, 1988
European Working Party on High Blood Pressure in the Elderly (EWPHE). Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly. Lancet 1: 1349–1354, 1985b
European Working Party on High Blood Pressure in the Elderly (EWPHE). An International Trial of Antihypertensive Therapy of Elderly Patients: objectives, protocol and organization. American Journal of Medicine 90(Suppl. 3A): 300–334, 1985a
Farnett L, Mulrow CD, Linn WD, et al: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? Journal of the American Medical Association 265: 489–495, 1991
Food and Drug Administration. Proposed guidelines for the clinical evaluation of antihypertensive drugs. Food and Drug Administration, Division of Cardio-Renal Products, Rockville, 1989b
Food and Drug Administration. US Department of Health and Human Services, Guidelines for the study of drugs likely to be used in the elderly. Center for Drug Evaluation and Research, Rockville, 1989a
Freiman JA, Chalmer TC, Smith H, et al. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. New England Journal of Medicine 299: 690–694, 1978
Furberg CD, Black DM. The systolic hypertension in the elderly pilot program: methodological issues. European Heart Journal 9: 223–227, 1988
Gardner MJ, Altman DG. Estimating with confidence. British Medical Journal 296: 1210–1211, 1988
Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. British Medical Journal 292: 810–812, 1986
Gifford RH, Feinstein AR. A critique of methodology in studies of anticoagulant therapy for myocardial infarction. New England Journal of Medicine 280: 351–357, 1969
Gurland BJ, Teresi J, McFate Smith W, et al. Effects of treatment for isolated hypertension on cognitive status and depression in the elderly. Journal of the American Geriatric Society 36: 1015–1022, 1988
Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Persistence of reduction in blood pressure and mortality of participants in the Hypertension Detection and Follow-up Program. Journal of the American Medical Association 259: 2113–2122, 1988
Hypertension Detection and Follow-up Program (HDFP) Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. II. Mortality by race, sex and age. Journal of the American Medical Association 242: 2572–2577, 1979
Irey NS. Diagnostic problems in drug-induced diseases. In Meyler L, Peck HM (Eds) Drug-induced diseases, Vol. 4, pp. 5–24, Excerpta Medica, Amsterdam, 1972
Julius S, Jamerson K, Mehia A, et al. The association of borderline hypertension with target organ changes and higher coronary risk. Journal of the American Medical Association 264: 364–358, 1990
Kitler ME. Clinical trials in the elderly: pivotal points. Clinics in Geriatric Medicine 6: 235–255, 1990a
Kitler ME. Dose-response relationship focus: the elderly. In Kuhlman J & Wingender W (Eds) Dose-response relationship of drugs, pp. 27–32, W. Zuckschwerdt Verlag, San Francisco, 1990b
Kitler ME. The changing face of clinical trials. Journal of Hypertension 6(Suppl. 1): 73–80, 1988
Kitler ME. The elderly in clinical trials: regulatory concerns. Drug Information Journal 23: 123–137, 1989
Kitler ME, Armitage P, (Eds) Clinical trials: a practical tool in cardiology. European Heart Journal 9: 203–234, 1988
Kitler ME. Clinical trials in hypertension: the present and perspectives for the future. Journal of Hypertension 8(Suppl. 4): 53–59, 1990c
Lamy PP. Adverse drug effects. Clinics in Geriatric Medicine 6: 293–307, 1990
Langer RD, Ganiats TG, Barrett-Connor E. Paradoxial survival of elderly men with high blood pressure. British Medical Journal 209: 1356–1357, 1989
Levy RI. The decline in cardiovascular disease mortality. Annual Review of Public Health 2: 49–70, 1981
Lionel NDM, Herxheimer A. Assessing reports of therapeutic trials. British Medical Journal 3: 637–640, 1970
Lipsitz LA. Altered blood pressure homeostasis in advanced age: clinical and research implications. Journal of Gerontology 44: 179–183, 1989
Lyles MF. Adverse effects of antihypertensive therapy. Clinics in Geriatric Medicine 5: 691–702, 1989
MacMahon SW, Jeffrey AC, Furberg CD, et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Progress in Cardiovascular Diseases 24: 99–118, 1986
MacMahon S, Cutler J, Stamler J. Antihypertensive drug treatment: potential, expected and observed effects on stroke and coronary artery disease. Hypertension 13(Suppl. 5): 145–150, 1989
Management Committee. Treatment of mild hypertension in the elderly: a study initiated and administered by the National Heart Foundation of Australia. Medical Journal of Australia 2: 398–402, 1981
Matilla K, Haavisto M, Rajala S, et al. Blood pressure and five year survival in the very old. British Medical Journal 296: 887–889, 1988
Maxwell MH, Ford CE. Cardiovascular mortality and morbidity in HDFP patients 50–69 years old at entry. Journal of Cardiovascular Pharmacology 7(Suppl. 2): S6–S9, 1985
Medical Research Council (MRC) Working Party. MRC trial of mild hypertension: principle results. British Medical Journal 291: 197–204, 1985
Messerli FH, Ventura HO, Glade LB, et al. Essential hypertension in the elderly: hemodynamics, antravascular volume, plasma renin activity, and circulating catecholamine levels. Lancet 2: 983–985, 1983
Michel DJ, Knodel LC. Comparison of three algorithms used to evaluate adverse drug reactions. American Journal of Hospital Pharmacy 43: 1709–1714, 1986
Multiple Risk Factor Research Trial (MRFIT) Intervention Group. Mortality after 10½ years for hypertension participants in the Multiple Risk Factor Intervention Group. Circulation 82: 1616–1628, 1990
Ray WA, Schaffner W, Oates JA. Therapeutic choice in the treatment of hypertension. American Journal of Medicine (Suppl. 6C): 9–16, 1986
Reidenberg MM: The quality of clinical research. Clinical Pharmacology and Therapeutics 47: 669–670, 1990
Rose M, McMahan FG. Some problems with antihypertensive drug studies in the context of new guidelines. American Journal of Hypertension 3: 151–155, 1990
SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the ElderlyProgram (SHEP). Journal of the American Medical Association 265: 3255–3264, 1991
Simon R. Confidence intervals for reporting results of clinical trials. Annals of Internal Medicine 105: 429–435, 1986
Spilker B. Patient refusers, nonqualifiers, dropouts, dropins and discontinuers. Drug News Perspectives 3(1): 14–18, 1990
Staessen J, Bulpitt C, Clement D, et al. Relation between mortality and blood pressure in elderly patients with hypertension. British Medical Journal 289: 1552–1556, 1989
Stern MF. The recent decline in ischemic heart disease mortality. Annals of Internal Medicine 91: 630–640, 1979
Sulkava R, Erkinjuntti T. Vascular dementia due to cardiac arrhythmias systemic hypotension. Acta Neurologica Scandinavica 76: 123–127, 1987
Tyson JE, Furzan JA, Reisch JS, et al. An evaluation of the quality of therapeutic studies in perinatal medicine. Journal of Pediatrics 102: 10–13, 1983
Vagelos PR. Are prescription drug prices high? Science 252: 11080–1084, 1991
Weiler PG. Assessing the impact of antihypertensive therapy on quality of life in the elderly. Clinics in Geriatric Medicine 5: 703–716, 1989
Weinstein MC, Stason WB. Allocation of resources to manage hypertension. New England Journal of Medicine 296: 732–739, 1977
Wessely S, Nickson J, Cox B. Symptoms of low blood pressure: a population study. British Medical Journal 301: 362–365, 1990
Winker MA, Murphy MB. Isolated systolic hypertension in the elderly. Journal of the American Medical Association 265: 3301–3302, 1991
Wright Jr JT. Geriatric hypertension therapy: a guide to cost-effectiveness. Geriatrics 43: 55–62, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitler, M.E. Clinical Trials and Clinical Practice in the Elderly. Drugs & Aging 2, 86–94 (1992). https://doi.org/10.2165/00002512-199202020-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199202020-00002